| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/03/2006 | EP1651631A1 Bicyclic imidazol derivatives against flaviviridae |
| 05/03/2006 | EP1651623A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | EP0804200B1 Use of noribogaine derivatives for treating chemical dependency in mammals |
| 05/03/2006 | CN1768062A 7-alkinylamino-triazolopyrimidines, methods for the production and use thereof to combat harmful fungi and agents containing said compounds. |
| 05/03/2006 | CN1768061A Pyrazolo[1,5-a][1,3,5]triazine derivatives as cannabinoid receptor ligands |
| 05/03/2006 | CN1768060A 7-alkenylamino-triazolopyrimidines, method for the production thereof and use thereof in controlling harmful fungi and substances containing said triazolopyrimidines |
| 05/03/2006 | CN1768051A Substituted pyrazoles |
| 05/03/2006 | CN1765899A Diazabicyclic central nervous system active agents |
| 05/03/2006 | CN1765897A Lactochrome fermentation liquor extraction process |
| 05/02/2006 | US7038060 Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038047 Controlling phytopathology fungi |
| 05/02/2006 | US7038045 Pyrazolotriazines as kinase inhibitors |
| 05/02/2006 | US7038044 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates |
| 05/02/2006 | US7038042 Process for producing cyclic compound |
| 05/02/2006 | US7038041 Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037911 For thromboembolic disorder from unstable angina, acute coronary syndrome, myocardial infarction, ischemia, stroke, atherosclerosis |
| 05/02/2006 | US7037910 Pyridazino[6,1-c ][1,2,4]triazin-4-ones; mediate physiological and psychotropic effects; antagonists; antiemetics; |
| 05/02/2006 | US7037909 Tetracyclic compounds as c-Met inhibitors |
| 05/02/2006 | US7037902 Substituted triazolopyrimidine, pyridazinone, pyridine ordiazolohexahydroquinoline derivatives which bind to the erythropoietin receptor modulatin the domain of the recptor; bioassay |
| 04/27/2006 | WO2006044958A1 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 04/27/2006 | WO2006044903A1 HYDRATE OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]- PYRAMIDIN-7-YL}PHENYL)ACETAMIDE AND PROCESSES AND METHODS RELATED THERETO |
| 04/27/2006 | WO2006044762A2 Tetrahydro-5h-pyrimido[4,5-d]azepine derivatives useful for the treatment of diseases associated with the 5-ht2c receptor |
| 04/27/2006 | WO2006044687A2 Kinase inhibitors |
| 04/27/2006 | WO2006044504A1 Cgrp receptor antagonists |
| 04/27/2006 | WO2006044415A2 Carboxylic acid peri - substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006044000A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring |
| 04/27/2006 | WO2006043175A2 Process for preparing purine compounds |
| 04/27/2006 | WO2006019957A3 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | WO2005117909A3 Kinase modulators and methods of use |
| 04/27/2006 | WO2005058901A8 Novel 2-(piperazin-1-yl)- and 2-([1,4]diazepan-1-yl)- imidazo[4,5-d]pyridazin-4-one, production and use thereof as medicament for the treatment of diabetes mellitus |
| 04/27/2006 | US20060089499 Pyrazolopyrimidines and the use thereof for controlling harmful organisms |
| 04/27/2006 | US20060089498 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 04/27/2006 | US20060089496 inhibitors of trypsin-like serine proteases; anticoagulant agents to treat thromboembolic disorders |
| 04/27/2006 | US20060089362 N-(2- piperazinophenyl) methyl 3-(3-chlorophenyl)-pyrazolo-[1,5-a]-pyrimidine-6-amide; treats circulatory diseases such as diseases due to inflammation, circulatory disorders, enhanced proliferation activities, and the like, i.e., hypertension, diabetes, diabetic complications, arteriosclerosis |
| 04/27/2006 | US20060089358 5-[(4-aminopiperidin-1-yl)methyl]-N-[(1R)-1-phenylethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine, BMS-673675 for example; antiproliferative agents; inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | US20060089351 Neuropeptide receptor modulators |
| 04/27/2006 | US20060089313 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 04/27/2006 | US20060088786 Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus |
| 04/27/2006 | CA2584278A1 Process for preparing purine compounds |
| 04/27/2006 | CA2583828A1 Carboxylic acid peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583536A1 Cgrp receptor antagonists |
| 04/27/2006 | CA2583534A1 Cgrp receptor antagonists |
| 04/26/2006 | EP1650266A1 Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same |
| 04/26/2006 | EP1650212A2 Optically active quaternary ammonium salt, process for producing the same, and process for producing optically active alpha-amino acid derivative with the same |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1649017A1 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 04/26/2006 | EP1648904A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 04/26/2006 | EP1648899A2 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 04/26/2006 | EP1648898A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/26/2006 | EP1648897A1 N- [3-(3-substituted-pyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-sulfonamides, and compositions, and methods related thereto |
| 04/26/2006 | EP1648896A1 7-substituted 3-nitro-pyrazolo [1,5-a] pyrimidines |
| 04/26/2006 | EP1648873A2 Neuroprotective macrocylic compounds and methods for their use |
| 04/26/2006 | EP1648867A1 Ppar active compounds |
| 04/26/2006 | EP1648408A1 Azepine derivatives as pharmaceutical agents |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | CN1764648A hydroxamid acid derivatives as histone deacetylase (HDAC) inhibitors |
| 04/26/2006 | CN1763041A N,Núº-dipyridyl-equibenzyl-tetraformyldiimine derivative and its synthesis method |
| 04/26/2006 | CN1763035A Oligothiophene-arylene derivatives and organic thin film transistors using the same |
| 04/25/2006 | US7034155 Method for producing n-ethyl-n-[3-(3-cyanopyrazolo[1,5a]pyrimidine-7-yl)phenyl]acetamide |
| 04/25/2006 | US7034154 Reacting a pyrazole with an enaminone to yield a halopyrazol-opyrimidine which is reacted with 2-thiophenecarboxylic acid chloride in the presence of zinc or magnesium or 2-thiophene boronic acid in the presence of carbon monoxide |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034151 1,4-dihydro-4-oxo-pyrrolo[2,1-f][1,2,4]triazine-6-carboxylates; novel approach to the formation of the bicyclic heterocyclic ring system |
| 04/25/2006 | US7034148 Metallocenyl phthalocyanines as optical recording media |
| 04/25/2006 | US7034032 1,2,3-triazolo(4,5-d)pyrimidine compounds used to treat cardiovascular disorders |
| 04/25/2006 | US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034023 Antidepressants, anxiolytic agents; corticotropin releasing factor receptor antagonist |
| 04/25/2006 | US7034016 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives |
| 04/25/2006 | US7033575 Delivery of physiologically active compounds through an inhalation route |
| 04/20/2006 | WO2006042289A2 Substituted biaryl quinolin-4-ylamine analogues |
| 04/20/2006 | WO2006041968A1 Reversed pyrimidinone compounds as calcilytics |
| 04/20/2006 | WO2006041773A2 Lactam compounds useful as protein kinase inhibitors |
| 04/20/2006 | WO2006040036A1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 04/20/2006 | WO2006019668A3 (1s,5s)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| 04/20/2006 | WO2006018609A3 Anti-inflammatory agents |
| 04/20/2006 | WO2005115398A3 Hiv integrase inhibitors |
| 04/20/2006 | WO2005111039A3 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084803 Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 04/20/2006 | US20060084801 for the treatment of cognitive disorders, anxiety, schizophrenia, and Alzheimer's disease; 10-chloro-9H-imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine; ligands; GABA A alpha 5 receptor inhibitors; halogenation |
| 04/20/2006 | US20060084669 reaction of Isatoic anhydride with 2-pyrrolidone to form pegen-9-one-8 and easy crystallization for pure recovery then Clemmensen reduction of the pegenone intermediate to produce 1,2,3,9-tetrahydropyrrolo[2,1-b]chinazoline (deoxypeganine) |
| 04/20/2006 | US20060084664 Substituted pyrido(1,2-A) pyrimidines and their use as NOS inhibitors |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084655 Reverse-turn mimetics and method relating thereto |
| 04/20/2006 | US20060084654 Imidazopyrazine tyrosine kinase inhibitors |
| 04/20/2006 | US20060084653 Beta-sheet mimetics and composition and methods relating thereto |
| 04/20/2006 | US20060084651 Chemical compounds |
| 04/20/2006 | US20060084650 Kinase inhibitors |
| 04/20/2006 | US20060084642 gamma-aminobutyric acid GABA receptors inverse agonists ; Alzheimer's disease, cognition enhancers; 10-methyl-9H-imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine |
| 04/20/2006 | CA2582985A1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 04/20/2006 | CA2582235A1 Lactam compounds useful as protein kinase inhibitors |
| 04/19/2006 | EP1646633A1 Beta-strand mimetics and method relating thereto |
| 04/19/2006 | EP1646631A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof |